From Chronic Inflammation to Colitis-Associated Colorectal Cancer: Field Cancerization and Clonal Evolution

Ulcerative colitis (UC) is associated with an increased risk of colorectal cancer, particularly in patients with long-standing and extensive disease. Although advances in medical therapy and surveillance have reduced colorectal cancer incidence, prolonged preservation of chronically inflamed colonic mucosa has increased the importance of understanding how cumulative inflammation promotes carcinogenesis. UC-associated neoplasia differs from sporadic colorectal cancer in its multifocality, pathological heterogeneity, and molecular evolution. Repeated inflammation, epithelial injury, and regeneration promote the accumulation of somatic and epigenetic alterations across histologically non-dysplastic mucosa, generating a cancerized field composed of genetically heterogeneous epithelial clones. Recent sequencing studies have shown that many clones selected in chronically inflamed mucosa harbor alterations that enhance adaptation to inflammatory stress but are not necessarily premalignant, indicating that field cancerization represents a dynamic evolutionary ecosystem rather than simple expansion of cancer-prone clones. Neoplastic progression requires further clonal selection as the selective environment shifts toward autonomous growth. Colitis-associated colorectal cancer is characterized by early TP53 alterations, a relatively late and less frequent involvement of APC, branching clonal evolution, and substantial copy-number alterations, particularly during progression from low- to high-grade dysplasia. Thus, colitis-associated carcinogenesis can be understood as a process in which chronic inflammation establishes a genetically altered field, followed by dynamic clonal selection and genomic evolution. Elucidating these processes may enable identification of high-risk fields and clones before invasive cancer develops and provide a biological basis for improved surveillance, risk stratification, and chemoprevention.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-10-09
DOI
https://doi.org/10.3390/cancers18203247
Primary Topic
Genetic factors in colorectal cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From Chronic Inflammation to Colitis-Associated Colorectal Cancer: Field Cancerization and Clonal Evolution

Mamoru Uemura, Atsushi Hamabe, Ryota Mori, Tsunekazu Mizushima et al.
Cancers
Genetic factors in colorectal cancer
article

From Chronic Inflammation to Colitis-Associated Colorectal Cancer: Field Cancerization and Clonal Evolution

Mamoru Uemura, Atsushi Hamabe, Ryota Mori, Tsunekazu Mizushima, Yuki Sekido, Mitsunobu Takeda, Takayuki Ogino, Masaaki Miyo, Norikatsu Miyoshi, Hidetoshi Eguchi
article en

Abstract

Ulcerative colitis (UC) is associated with an increased risk of colorectal cancer, particularly in patients with long-standing and extensive disease. Although advances in medical therapy and surveillance have reduced colorectal cancer incidence, prolonged preservation of chronically inflamed colonic mucosa has increased the importance of understanding how cumulative inflammation promotes carcinogenesis. UC-associated neoplasia differs from sporadic colorectal cancer in its multifocality, pathological heterogeneity, and molecular evolution. Repeated inflammation, epithelial injury, and regeneration promote the accumulation of somatic and epigenetic alterations across histologically non-dysplastic mucosa, generating a cancerized field composed of genetically heterogeneous epithelial clones. Recent sequencing studies have shown that many clones selected in chronically inflamed mucosa harbor alterations that enhance adaptation to inflammatory stress but are not necessarily premalignant, indicating that field cancerization represents a dynamic evolutionary ecosystem rather than simple expansion of cancer-prone clones. Neoplastic progression requires further clonal selection as the selective environment shifts toward autonomous growth. Colitis-associated colorectal cancer is characterized by early TP53 alterations, a relatively late and less frequent involvement of APC, branching clonal evolution, and substantial copy-number alterations, particularly during progression from low- to high-grade dysplasia. Thus, colitis-associated carcinogenesis can be understood as a process in which chronic inflammation establishes a genetically altered field, followed by dynamic clonal selection and genomic evolution. Elucidating these processes may enable identification of high-risk fields and clones before invasive cancer develops and provide a biological basis for improved surveillance, risk stratification, and chemoprevention.

CancersVol. 18(20)
Osaka City University (JP), Dokkyo Medical University (JP)
Openalex Percentile: Top 12%
Genetic factors in colorectal cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.